(-0.08%) 5 465.07 points
(0.06%) 39 135 points
(0.16%) 17 746 points
(0.04%) $80.86
(-5.04%) $2.62
(-0.81%) $2 311.90
(-0.06%) $28.85
(3.28%) $1 018.80
(0.35%) $0.936
(0.72%) $10.68
(0.50%) $0.792
(-0.28%) $87.25
5 days till quarter result
(bmo 2024-07-01)
Expected move: +/- 4.92%
Live Chart Being Loaded With Signals
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans...
Stats | |
---|---|
Dagens volum | 138 938 |
Gjennomsnittsvolum | 194 777 |
Markedsverdi | 213.62M |
Neste inntjeningsdato | ( $-0.300 ) 2024-07-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0200 (0.45%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-06 | Bessemer Venture Partners Vii L.p. | Buy | 4 770 901 | Common Stock |
2024-02-06 | Bessemer Venture Partners Vii L.p. | Sell | 3 161 709 | Series B Preferred Stock |
2024-02-06 | Bessemer Venture Partners Vii L.p. | Sell | 2 236 537 | Series C-1 Preferred Stock |
2024-02-06 | Bessemer Venture Partners Vii L.p. | Sell | 1 953 271 | Series A Preferred Stock |
2024-02-06 | Bessemer Venture Partners Vii L.p. | Sell | 1 625 698 | Series C-2 Preferred Stock |
INSIDER POWER |
---|
-32.74 |
Last 41 transactions |
Buy: 15 629 342 | Sell: 30 947 547 |
Volum Korrelasjon
Fractyl Health, Inc. Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Fractyl Health, Inc. Korrelasjon - Valuta/Råvare
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Fractyl Health, Inc.
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is based in Lexington, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.